Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up…
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up…
The German companies Evonik and Beiersdorf will work together on a joint research project to…
Researchers in Germany and France have combined synthetic biology with microfluidics to create artificial photosynthetic…
The Heidelberg-based startup Velabs Therapeutics aims to make anti-aging drugs that selectively destroy ‘aged’ cells…
German biotech company Cardior Pharmaceuticals’ candidate heart failure drug has the potential to stop the…
Biotech company HepaRegeniX has raised a Series B round that will allow its first…
An international collaboration called BioRescue has taken a step forward in bringing back the Northern…
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
Berlin-based startup Legendairy Foods has raised €4M to develop cheese and other dairy products…
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of…
The German biotech ViGeneron has raised an undisclosed sum in a Series A round to…